Exact Sciences Announces Preliminary Fourth Quarter 2021 Results

MADISON, Wis., Jan. 9, 2022 /PRNewswire/ — Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company expects to report revenue between $472 million and $475 million for the fourth quarter ended Dec. 31, 2021. “The Exact Sciences team delivered outstanding results to finish…